/
CNC
$64.22-$0.32 (-0.50%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$32.5B
494M shares
52-week range
$25.08 – $66.55
94% from low
Sector
HOSPITAL & MEDICAL SERVICE PLANS
Exchange
NYSE
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-9.44
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $60.12B | $74.64B | $111.11B | $125.98B | $144.55B | $154.00B | $163.07B | $194.78B |
| Cost of revenue | $51.70B | $65.80B | $95.90B | $111.78B | $127.89B | $136.68B | $146.24B | $170.94B |
| Gross profit | $8.42B | $8.84B | $15.22B | $14.20B | $16.66B | $17.32B | $16.83B | $23.83B |
| Gross margin | 14.0% | 11.8% | 13.7% | 11.3% | 11.5% | 11.2% | 10.3% | 12.2% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $1.46B | $1.78B | $3.08B | $1.78B | $1.32B | $2.93B | $3.17B | −$7.62B |
| EBITDA | $2.21B | $2.84B | $4.76B | $3.81B | $4.06B | $5.62B | $6.20B | −$5.14B |
| Net income | $900.0M | $1.32B | $1.81B | $1.35B | $1.20B | $2.70B | $3.31B | −$6.67B |
| Net margin | 1.5% | 1.8% | 1.6% | 1.1% | 0.8% | 1.8% | 2.0% | -3.4% |
| EPS (diluted) | 2.26 | 3.14 | 3.12 | 2.28 | 2.07 | 4.95 | 6.31 | -13.62 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $191.0B | $3.50 | $3.43–$3.63 | 13 |
| 2027 | $191.2B | $4.52 | $4.03–$4.80 | 12 |
| 2028 | $198.4B | $6.07 | $4.89–$7.20 | 6 |
| 2029 | $203.3B | $7.21 | $6.98–$7.43 | 4 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$124.99
Price
$64.22
Implied upside
+95%
Peer comparison
Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
www.centene.com- Employees
- 61,100
- IPO / List date
- Dec 13, 2001
- HQ
- ST LOUIS, MO
Held by traders on TradeandTell
No one on the platform currently holds CNC.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,684,669 | $55.2M |
| Bridgewater Associatesas of 2026-03-31 | 168,146 | $5.5M |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2019-02-07 | 2-for-1 |
| 2015-02-20 | 2-for-1 |
Recent trades on TradeandTell
No one on the platform has traded CNC yet.
